Sale is live|00:00:00left today

Repligen Corporation Common Stock

RGEN

Biotechnology: Biological Products (No Diagnostic Substances)

$122.73

Market Cap

$7M

P/E Ratio

—

Revenue Rank

—

Margin Rank

—

Earnings Analysis Coming Soon

We're processing earnings call transcripts for this company. Check back soon for AI-powered insights.

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings calls Stock ScreenerFilter by P/E, ROE, growth & more IPO DashboardUpcoming, open & listed IPOs Compare StocksSide-by-side stock comparison CalculatorsSIP, CAGR, EMI & more Earnings CalendarUpcoming earnings calls Analyze PortfolioAI health check for your portfolio BlogMarket insights & guides